FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

SCA Pharmaceuticals Fentanyl Recall

Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821…

SCA Pharmaceuticals · Windsor, CT

Risk level
Class III
Reported by FDA
Dec 23, 2020
Recall ID
D-0147-2021
Check your lot numberHow we source this data

Summary

SCA Pharmaceuticals recalled Fentanyl starting Nov 20, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0147-2021 on Dec 23, 2020. Reason: Subpotency: Out-of-specification stability test result for low potency was obtained. Status: Terminated.

Why it was recalled

Subpotency: Out-of-specification stability test result for low potency was obtained.

Product description

Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205

Lot numbers, UPCs & expiration codes

Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021

Where it was sold

Product was distributed to three hospitals in MO & LA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0147-2021
Classification
Class III
Status
Terminated
Recall initiated
Nov 20, 2020
FDA report date
Dec 23, 2020
Quantity
4,843 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
SCA Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0147-2021, exactly as published.

Show all FDA fields
City
Windsor
State
CT
Status
Terminated
Country
United States
Event ID
86802
Address
755 Rainbow Rd Ste B
Code information
Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021
Postal code
06095-1024
Report date
Dec 23, 2020
Product type
Drugs
Recall number
D-0147-2021
Classification
Class III
Recalling firm
SCA Pharmaceuticals
Product quantity
4,843 syringes
Termination date
Jun 24, 2021
Reason for recall
Subpotency: Out-of-specification stability test result for low potency was obtained.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205
Distribution pattern
Product was distributed to three hospitals in MO & LA.
Recall initiation date
Nov 20, 2020
Initial firm notification
Letter
Center classification date
Dec 14, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0147-2021, published Dec 23, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls